Serato, Baby Boy .
HRN: 22-58-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/09/2023
CEFTAZIDIME 1GM (VIAL)
03/09/2023
03/15/2023
IV
130mg
Q12
T/c UTI With Moderate Dehydration; R/o Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes